This interview is a great introduction to the world of photobiomodulation (PBM) and 1070nm light stimulation specifically. Prof. Paul Chazot, Chair of Pharmacology at Durham University (UK) and Quietmind Foundation have been collaborating for over 17 years and publishing several papers on the use of 1070nm transcranial PBM. His comments covers 1070nm research history and the broader and profound implications on how icPBM fits into developing noninvasive therapies for Alzheimer's, Parkinson's, ALS, and traumatic brain injury.
Quietmind is now developing treatment protocols for use with the Neuradiant (TM) 1070 technology. Call 267-481-3987 to arrange a consultation. Click here to watch the interview: https://www youtube com/watch?v=sNmL_gLM6k0
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
QMF NewsOur team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. Archives
June 2025
Categories
All
|